Elanco Animal Health Incorporated Common Stock (NY:ELAN)

22.56 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

1 Healthcare Stock Worth Your Attention and 2 We Turn Down

October 09, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...

Via StockStory

2 Cash-Producing Stocks for Long-Term Investors and 1 Facing Headwinds

October 06, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

1 Mid-Cap Stock to Keep an Eye On and 2 We Ignore

October 05, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain Ground ↗

September 26, 2026

Elanco Animal Health (NYSE:ELAN) President and CEO Jeff Simmons outlined the company’s growth strategy, product launches, deleveraging plans and outlook for its pet health and farm animal businesses...

Via MarketBeat

Elanco Animal Health (NYSE:ELAN) Q2 Earnings Beat, Lifts Full-Year Outlook ↗

August 05, 2026

Via Chartmill

Topics Earnings

Elanco Animal Health Inc (NYSE:ELAN) Technical Breakout Setup Scores 10/10 Technical Rating and 9/10 Setup Quality ↗

July 04, 2026

Via Chartmill

3 Reasons to Sell ELAN and 1 Stock to Buy Instead

September 15, 2026

Elanco currently trades at $23.15 per share and has shown little upside over the past six months, posting a small loss of 1.1%. The stock also fell short of ...

Via StockStory

Elanco Director Purchases 40,000 Shares for $936,000 ↗

September 04, 2026

Purchasing 40,000 shares is a bullish signal for shareholders.

Via The Motley Fool

Topics Regulatory Compliance

Insiders Are Betting Big on These 3 Healthcare Stocks ↗

August 31, 2026

Insiders are buying shares of Braveheart Bio, BlossomHill Therapeutics and Elanco, three health care stocks with differing risk profiles, analyst ratings, and pipeline catalysts ahead.

Via MarketBeat

Topics Initial Public Offering

3 Stocks Under $50 That Concern Us

August 28, 2026

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...

Via StockStory

2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down

August 25, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

Topics Economy Energy

Director's Confidence Visible as Elanco Leader Buys 10,000 Shares ↗

August 19, 2026

Insider buys into strength as the Elanco stock price has outperformed the S&P 500 over the last 12 months.

Via The Motley Fool

Topics Regulatory Compliance Stocks

1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 We Find Risky

August 17, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

Elanco (ELAN) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Zenrelia and Credelio Quattro drove blockbuster growth and margin expansion.

Via The Motley Fool

Topics Earnings

5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call

August 12, 2026

Elanco’s results for the second quarter were positively received by the market, reflecting momentum across both its Pet Health and Farm Animal businesses. Ma...

Via StockStory

Topics Earnings

Elanco Animal Health Q2 Earnings Call Highlights ↗

August 08, 2026

Elanco Animal Health (NYSE:ELAN) reported second-quarter 2026 revenue of $1.368 billion, up 10% on a reported basis and 8% organically in constant currency, as demand for new pet-health products and...

Via MarketBeat

Topics Earnings

ELAN Q2 Deep Dive: Blockbuster Launches and Portfolio Expansion Drive Outperformance

August 06, 2026

Animal health company Elanco (NYSE:ELAN) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.2% year on year to $1.37 bill...

Via StockStory

Elanco’s (NYSE:ELAN) Q2 CY2026: Strong Sales, Stock Soars

August 05, 2026

Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 10.2% year on year to $1.37 billion...

Via StockStory

Elanco (ELAN) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 03, 2026

Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before market hours. Here’s what you need to know. Elanco beat analysts’ re...

Via StockStory

1 Mid-Cap Stock to Own for Decades and 2 We Question

June 24, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

Topics Retirement

1 Profitable Stock to Target This Week and 2 We Avoid

June 16, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

2 Cash-Producing Stocks on Our Buy List and 1 That Underwhelm

June 12, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

3 of Wall Street’s Favorite Stocks We Think Twice About

June 01, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

3 Healthcare Stocks We Keep Off Our Radar

May 28, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...

Via StockStory

What This Fund's $20 Million Sale Says About a Packaging Giant Facing a Turnaround Test ↗

May 23, 2026

Graphic Packaging supplies fiber-based packaging for global consumer and foodservice brands, with a focus on sustainability and scale.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About This Fund's $85 Million Lionsgate Buy During a Breakout Quarter ↗

May 23, 2026

Lionsgate Studios leverages a vast film and TV library to serve global broadcasters, streamers, and distributors with premium content.

Via The Motley Fool

Topics Intellectual Property

Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks

May 20, 2026

Looking back on pharmaceuticals stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Elanco (NYSE:ELAN) and its peers. The pha...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Black Creek trims PriceSmart after a strong run — conviction intactBlack Creek trims PriceSmart after a strong run — conviction intact ↗

May 19, 2026

PriceSmart runs membership warehouse clubs across the Americas, providing essential goods and services to value-driven customers.

Via The Motley Fool

Topics Regulatory Compliance

3 Reasons to Sell ELAN and 1 Stock to Buy Instead

May 15, 2026

Since November 2025, Elanco has been in a holding pattern, floating around $21.39. The stock also fell short of the S&P 500’s 11.5% gain during that period. ...

Via StockStory

Topics Stocks

5 Insightful Analyst Questions From Elanco’s Q1 Earnings Call

May 13, 2026

Elanco’s first quarter results were met with a positive market reaction, as management pointed to broad-based revenue growth across its pet health and farm a...

Via StockStory

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.